Background: Catheter ablation of ventricular arrhythmias (VAs) arising from the left
| INTRODUC TI ON
The papillary muscles (PMs) of the left ventricle (LV) are potential sites of origin of ventricular arrhythmias (VAs).
1 Catheter ablation has been described as an effective treatment, although radiofrequency (RF) delivery at these regions has been associated with poor catheter stability and high recurrence.
2 Cryo-energy can provide stable contact and lower recurrence rates. 3, 4 Nevertheless, information regarding PM VAs ablation approaches is still lacking.
This study is meant as an up-date of our previous research, in which the use of contact force sensing catheters and advance electroanatomical mapping systems were lacking, as a major limitation. We sought to describe procedural outcomes and recurrence rates after catheter ablation of PM VAs using different energy sources: 1-Non-CFS RF, 2-Cryoablation (CRYO), and 3-CFS RF; with either 1-computed tomography integration (CTII) into the electroanatomical mapping system or 2-intracardiac echo-facilitated 3D electroanatomical mapping (ICE3D).
| ME THODS
A total of 53 patients with VAs originating at the LV PMs were identified from retrospective review of 352 consecutive patients (men 56%, age 49, range 23-57 years) with symptomatic sustained ventricular tachycardia (VT) (n = 106), non-sustained VT (n = 81), or PVCs (n = 165) referred to our institution for catheter ablation between January 2014
and January 2018. This study retrospectively included 53 patients with symptomatic, drug refractory VAs originated at the PMs. Patients with right ventricular (RV) PM VAs were not included in the study as we believe they should be addressed in a separate analysis, given their unique anatomical and electrophysiological characteristics. The study was approved by the institutional review committee and all subjects gave written informed consent. Ablation technique was selected according to the operator preferences and available technologies. All antiarrhythmic drugs were discontinued for at least five half-lives before the study.
Structural heart disease and mitral valve function were assessed by echocardiography prior ablation. All patients underwent electrophysiological study and catheter ablation. Catheter ablation was In patients presenting spontaneous PMs VAs with variable QRS, focal mapping and ablation of the clinical arrhythmia may be difficult as multiple exit sites may be involved. In those cases, a point-by-point circumferential ablation at the base of the PM was performed to modify all possible exit sites of the clinical arrhythmia, as previously reported by Wo et al.
5
Three segments were attributed to each PM: The apex, at the point of insertion of the chords (distal third of the PM); the body (middle portion of the PM); and the proximal third of the PM as the base, which is in continuity with the LV inferior wall. Catheter position, contact, and stability were assessed through intracardiac echocardiography (ICE), or ventriculography and 2D or 3D trans-esophageal ultrasound in cases where ICE was not available. Catheter stability was defined as the absence of back and forth movement of the catheter during energy delivery at the effective lesion site.
For patients treated without ICE3D, a multidetector computed tomography (MDCT) was obtained less than 15 days before catheter ablation (64-detector Phillips Brilliance; Phillips Medical Systems, Eindhoven, Netherlands). The cardiac MDCT image was then integrated into the electroanatomical mapping system.
Activation and pace mapping were performed in all cases. In cryoablation cases, activation points were collected using a decapolar catheter to avoid mapping with an 8 mm tip catheter. Pace mapping criteria was defined by a score determined from the R/S ratio and fine notching of the QRS in the 12-lead ECG (perfect pace mapping = 24 points), as previously reported. When a reduction in the incidence of VT or PVCs was observed cryoenergy was delivered for up to 240 seconds with two freeze-thaw-freeze cycles and RF was delivered for up to 90 seconds, with two posterior 45 seconds consolidation lesions at the same area; otherwise, energy delivery was terminated, and the catheter was repositioned.
The end-point of catheter ablation was the elimination and noninducibility of VAs during isoproterenol infusion (2-10 μg/min) and burst pacing from the RV to a cycle length as short as 300 milliseconds. Procedural acute success was defined as abolition of inducible or spontaneous ventricular arrhythmia. 
| ECG analysis

| Follow-up
All patients were monitored continuously for 24 hours after the ablation procedure. Electrocardiography and echocardiography were performed before discharge and during follow-up. Information was obtained from 
| Statistical analysis
Continuous data are expressed as mean ± SD and categorical data are presented as absolute values and percentages. Statistical analysis was performed using the Rank sum test for non-normally distributed variables and categorical variables were compared using the χ 2 test.
Kaplan-Meier curves were generated and the comparison among the two groups was performed using the Log-rank test. A multivariate analysis was performed using Cox regression, to determine the variables associated with clinical VA recurrence. Data analysis was executed with the SPSS software version 20 (SPSS, IBM Corporation, Buenos Aires, Argentina). For all tests, a P value of 0.05 or lower was considered statistically significant. Overall success and recurrence rates (N = 53 patients) were 92%
| RE SULTS
| Patient characteristics
and 30%, respectively. The population base line characteristics are sum up in Table 1 .
| Papillary muscle characteristics
The PMPM had higher prevalence of clinical arrhythmias (83% PMPM VAs vs 17% ALPM VAs). The PM base was the most frequent site of origin of VAs (Base 63%; Body 25%; Apex 12%).
Purkinje potentials (PP) were observed in 35 (59%) patients.
These PPs were present in 73% of VAs originating at the base of the PMs, while those VAs with origin at the body of the PMs only exhibited 33% prevalence, and none at the apex.
| Procedural outcomes
A total of 59 PMVAs were observed (Single morphology N = 55;
Variable QRS morphology N = 4). Termination of the arrhythmia was observed in 49 patients without further inducibility. Major complications were observed in one patient, who presented a non-surgical cardiac tamponade related to the transeptal puncture.
Patients treated with Non-CFS/CTII (n = 23) showed 83% acute success rate, while those treated with CFS RF/ICE3D (n = 14) and CRYO/CTII (n = 16) presented 100% acute success rate (P = 0.03).
Catheter stability was achieved in all patients treated with CRYO/CTII; 50% in those treated with CFS RF/ICE3D; and only in 26% of patients in the Non-CFS RF/CTII group (P = 0.001). Average contact force at the PM base was 18 ± 5 g, while the body and apex presented 8 ± 3 and 4 ± 2 g, respectively. Incidence of multiple VAs morphologies during energy delivery (pro-arrhythmia) was 78% for RF, and 0% for CRYO/ CTII (P = 0.001).
There were no differences between groups regarding ablation end-points such as VEGM-QRS interval >25 milliseconds and pacemapping score in patients treated with focal ablation, as seen in Table 2 .
The use of conscious sedation did not affect ablation outcomes when compared to general anesthesia, as observed in Table 4 .
| Follow-up outcomes
Follow-up results are summed up in Table 2 . There was no increase in the incidence of mitral valve regurgitation, or an increase of MR severity after ablation, using either method.
Clinical VA recurrence was 48% (n = 11) for those treated with Non-CFS RF/CTII; 19% (n = 3) for CRYO/CTII; and 7% (n = 1) for CFS RF/ICE3D (P = 0.02). A subgroup analysis showed no significant differences regarding recurrence between CRYO/CTII and CFS RF/ ICE3D (19% vs 7%; P = 0.6). One patient from the cryoablation group showed delayed success, with Holter burden reduction from 50% to <5% after 6 months. Figure 4 shows the free from VAs survival curves.
The use of antiarrhythmic drugs and Holter burden were reduced (93% vs 29%; P = 0.05 and 22 ± 9% vs 4 ± 7%; P = 0.006, respectively) after ablation, with the use of CFS RF/ICE3D.
Holter burden and anti-arrhythmic drugs reduction for CRYO/ CTII were 14 ± 10 to 3 ± 3% (P = 0.06) and 19% to 6% (P = 0.09),
respectively. The use of anti-arrhythmic drugs after Non-CFS/ CTII ablation showed a non-significant reduction (48% to 35%; P = 0.1) and Holter burden was reduced from 25 ± 10 to 14 ± 12% (P = 0.05), without achieving a clinical reduction of more than 85%. Non-CFRF/CTII, no contact force sensing RF and cardiac tomography integration into the electroanatomical mapping system; CFS RF/ICE3D, contact force sensing RF and intracardiac echofacilitated 3D electroanatomical mapping; CRYO/CTII, cryoablation and cardiac tomography integration into the electroanatomical mapping system; AHT, arterial hypertention; DBT, diabetes; LVEF, left ventricular ejection fraction; MVP, mitral valve prolapse; MR, mitral regurgitation; Bivalvar MVP, Bi-valvar MVP; MV Sx, prior mitral valve surgery; SHD, structural heart disease; NSVT, nonsustained ventricular tachycardia; VT, ventricular tachycardia; PVC, premature ventricular contractions.
TA B L E 1 Population general characteristics
| ECG analysis
Mean QRS duration of the clinical VA was 156 ± 15 milliseconds.
Clinical arrhythmias with an R > r` pattern in lead V1 were the most frequent among patients with single morphology QRS (79% vs 11%).
VAs with early precordial TZ were more frequently seen at the base of PMPM, while late precordial TZ was observed with VAs originating at the apex of the PMs. Arrhythmias originating at the PMPM showed a superior axis in 88% of cases, and 77% of VAs with origin at the ALPM presented an inferior axis. Electrocardiographic characteristics of single morphology PM VAs (N = 55) are summed up in Table 3 .
| Univariate and multivariate analysis
Univariate and multivariate analysis were performed using Cox regression, to predict which variable was associated with an increased risk of clinical VA recurrence. The use of Non-CFS RF catheters was the sole variable associated with a higher risk of recurrence, as seen in Table 4 .
| D ISCUSS I ON
| Main findings
This study demonstrated that: (a) Regarding overall success, both CRYO/CTII and CFS RF/ICE3D approaches were equally effective, while the use on Non-CFS RF/CTII was associated with a 4. Regarding catheter stability and possible pro-arrhythmic effect:
All patients treated with CRYO/CTII presented stable contact TA B L E 2 Procedure characteristics and pro-arrhythmia was non-existent during cryoablation, while almost 80% of patients treated with RF showed variable QRS VAs during energy delivery, which account for a pro-arrhythmic effect of RF. Although catheter stability was significantly improved with the use of CFS RF/ICE3D, it was only achieved in 50% of patients.
We believe this was primarily thanks to ICE3D rather than contact force sensing by providing better anatomical landmarks, thus improving catheter navigation. Stable contact may not be the sole determinant for successful ablation. (c) Regarding contact force sensing: this was higher at the base of the PMs, as the catheter tends to wedge at this location, in contrast to non-basal aspects of the PM, where the catheter tends perform a brushing-like movement as good contact is harder to obtain. Cryo-ablation may be a suitable alternative as catheter-adherence may overcome contact limitations at these locations.
| Papillary muscles' electrophysiological characteristics
The prevalence of spontaneous VAs with variable QRS was very low in this cohort of patients, which is inconsistent with the literature.
The base of the posteromedial PM was the most arrhythmogenic site of origin. The most frequent QRS pattern was R < r'. Early precordial TZ was more frequently observed in VAs originating at the base of the PM, while late TZ was associated with a more distal (chordae in- 
| Prior studies
It has been reported that almost half of the patients with PM VAs may present with variable QRS morphologies. 7 In this scenario, recurrence after RF ablation can be as high as 60%. 8, 9 Spontaneous variable QRS morphologies may respond to preferential conduction to multiple breakout sites, due to an anisotropic mechanism given the complexity of the myocardial strands distribution between the base and apex of the PM. Months since Procedure CFS-ICE3D Cryo Non-CFS site of VA origin may be located away from the breakout site. [9] [10] [11] [12] Purkinje potentials can be observed in 45% of PM VAs.
3 They are frequently recorded at the base of the PMs at the Purkinje-fibbermuscular interface, and rarely at a distal aspect, suggesting that the Purkinje network may not extend further toward the chordae insertion site and that VAs may arise from the myocardium itself.
3
Distal Purkinje fibbers may be involved in triggering or maintaining PM VAs. 5, 10, 11, 13 The latter is supported by a recent description of PM fascicular VT (PM-FVT), which shares a similar QRS morphology of FVT, 6 presenting RBBB with r < R' configuration.
Monomorphic ventricular PVCs originating from the PMs have been found to initiate idiopathic ventricular fibrillation or polymorphic VT, either in structurally normal hearts or in patients with bileaflet mitral valve prolapse. [14] [15] [16] [17] Our previous studies showed that cryoablation of single morphology VAs with origin at the PMs of the LV was more effective than Non-CFS RF/CTII. 3, 4 These results remain the same in the current study, and the enhanced result of RF were attributed to the addition of CFS catheters and specially to the use of intracar- 
| Study limitations
This is not a randomized trial comparing different energy sources or mapping techniques for catheter ablation of PM related arrhythmias.
Patients were treated depending on the available technology, as contact force catheters or ICE3D were not available at early stages.
Cryoablation was not implemented together with CARTOSOUND due to higher costs. These may have accounted for a selection bias.
Ablation outcomes may have been influenced by operator experience and learning curve, although all operators have previous experience with PM catheter ablation before this study.
We defined stability as the absence of back and forth movement (brushing-like motion) of the catheter. Although cryo-catheter adherence does represent a technical advantage, in this scenario it did not affect outcomes. We believe that ICE3D does improve stability, although RF will not allow for catheter adherence. These results were conditioned by our definition of catheter stability.
The small number of patients treated using a circumferential catheter ablation approach does not allow to make any assumption regarding outcomes between the latter and focal ablation.
| CON CLUS IONS
The use of Non-CFS RF/CTII was associated with a 4.6-fold increase risk of recurrence after catheter ablation of LV PM VAs. Ablation with either CFS RF/ICE3D or CRYO/CTII showed high acute success rates and low recurrence rates during follow-up and were safe alternatives. Cryoablation provided stable contact and was less arrhythmogenic. LVEF, left ventricular ejection fraction; CFS RF/ICE3D, contact force sensing radiofrequency ablation and intracardiac echo-facilitated 3D electroanatomical mapping; Non-CFS RF/CTII, non-contact force sensing ablation and cardiac tomography integration into the electroanatomical mapping system; CRYO/CTII, cryoablation and cardiac tomography integration into the electroanatomical mapping system; ICE, intracardiac echocardiography; SHD, structural heart disease; Transeptal, transeptal access; MVP, mitral valve prolapse.
TA B L E 4 Univariate and multivariate analysis
